Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2021 | 03-2021 | 01-2021 | 10-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,047 | -5,047 | -3,790 | -2,671 | N/A |
| Other Working Capital | -153 | -153 | 553 | 812 | 520 |
| Other Operating Activity | 2,488 | 2,488 | 1,783 | 1,211 | 591 |
| Operating Cash Flow | $-2,712 | $-2,712 | $-1,454 | $-648 | $1,111 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 101 | 101 | 101 | 101 | 0 |
| Investing Cash Flow | $101 | $101 | $101 | $101 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,850 | N/A | 800 | N/A | N/A |
| Debt Issued | 502 | N/A | 502 | 462 | N/A |
| Debt Repayment | -2 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,100 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 4,450 | 2 | 1 | 77 |
| Financing Cash Flow | $4,450 | $4,450 | $1,304 | $463 | $77 |
| Beginning Cash Position | 90 | 90 | 90 | 90 | N/A |
| End Cash Position | 1,929 | 1,929 | 41 | 6 | N/A |
| Net Cash Flow | $1,839 | $1,839 | $-50 | $-84 | $1,188 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,712 | -2,712 | -1,454 | -648 | 1,111 |
| Free Cash Flow | -2,712 | -2,712 | -1,454 | -648 | 1,111 |